Abstract

Candesartan Cilexitil 1 mg/mL Syrup

Author(s): Allen Loyd V Jr

Issue: May/Jun 2022 - Volume 26, Number 3

Page(s): 234

Download in electronic PDF format for $75
  • Candesartan Cilexitil 1 mg/mL Syrup Page 1

Note: Electronic version includes supplemental material.

Abstract

A formulation for preparing Candesartan Cilexitil 1 mg/mL Syrup. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • candesartan cilexitil
  • antihypertensive agent
  • hypertension
  • high blood pressure
  • angiotensin II receptor antagonist

Related Categories

  • FORMULATIONS
  • CARDIOLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
May/Jun 2022
Pg. 234
Candesartan Cilexitil 1 mg/mL Syrup
Author(s): Allen Loyd V Jr
May/Jun 2017
Pg. 232
Candesartan Cilexetil 0.1-mg/mL to 2.0-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Jul/Aug 2019
Pg. 315
Candesartan Cilexetil 1 mg/mL in Syrup NF or Vehicle for Oral Solution USP
Author(s): Allen Loyd V Jr
Mar/Apr 2017
Pg. 147
Candesartan Cilexetil 8 mg Liquid-Filled Capsules
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
May/Jun 2007
Pg. 248
Losartan Potassium 2.5-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Mar/Apr 2020
Pg. 139
Valsartan 4 mg/mL in Syrup NF
Author(s): Allen Loyd V Jr
Sep/Oct 2019
Pg. 412
Valsartan 4 mg/mL in Vehicle for Oral Solution USP
Author(s): Allen Loyd V Jr
Jul/Aug 2023
Pg. 326
Losartan Potassium 2.5-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
May/Jun 2005
Pg. 201-205
Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs
Author(s): Harrington Catherine A, Cauffield Jacintha
Mar/Apr 2005
Pg. 117-119
Combating Cardiovascular Disease With Compounded Medications. Part 1: Combination Cardiac Medicines to Control Blood Pressure
Author(s): Harrington Catherine A, Cauffield Jacintha
Sep/Oct 2019
Pg. 413
Verapamil Hydrochloride 50 mg/mL in Ora-Plus:Ora-Sweet (1:1)
Author(s): Allen Loyd V Jr
May/Jun 2019
Pg. 237
Valsartan 16-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Jul/Aug 2014
Pg. 330
Propranolol Hydrochloride 1-mg/mL Injection
Author(s): Allen Loyd V Jr
Sep/Oct 2008
Pg. 392-397
Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases
Author(s): Mixon William, Helms Scott R
Jul/Aug 2023
Pg. 340-346
Formulation and In Vitro Evaluation of a Ramipril Entrapped in a Microsponge-based Drug-delivery System
Author(s): Taghi Hassanien Sagban, Abdulbaqi Mustafa R, Samein Laith Hamza, Rahmani Maha H Philip
Jul/Aug 2002
Pg. 288-292
Basics of Compounding for Iontophoresis, Part II
Author(s): Allen Loyd V Jr
May/Jun 2018
Pg. 233
Atenolol 1 mg/mL or 5 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr